StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > The sudden Rise

<< Previous

Bullboard Posts

Next >>

Comment by Directvoiceon Feb 17, 2021 10:38pm

207 Views

Post# 32592651

RE:The sudden Rise

The only think that come in mind is accumulation from a big player. The buy happens at the close two days in a row. It also an interesting stock in a crucial technology. Illumina will launch his test soon. Big players will try to be in that market making Stage Zero a potential target acquisition.

<< Previous

Bullboard Posts

Next >>

Debt-free cannabis company set for next stage of growth